They Do Well Who Do Good is a collection of articles written from 2000 to 2010 that document the changes in the Japan health care system and pharma industry. Changes considered impossible in the past became routine. As the decade ended, optimists and game changers leave the pessimists and status quo keepers behind. An attractive health care system evolved to care for an aging population with chronic diseases versus a young population with acute diseases. Japan wants the best health care the world has to offer, but choices must be made because resources to pay the bill are limited. In the beginning of the decade, you could compare Japanese pharma companies to a convoy of ships. Some big, some small, some fast, some slow, but all moved together. Ten years later, the convoy analogy was no longer useful. Some went abroad, others stayed home. Some divested noncore businesses; others did not. Some merged; others choose to go alone. Some changed their business models and cultures. Other rejected change and held on to their past. They Do Well Who Do Good is an insider's perspective on what it takes to succeed in Japan's pharma market.

It's Worth Doing is a must read for anyone engaged in cross-border dealings with Japan in the pharmaceutical industry. This book offers a wealth of insight that you will find invaluable whether you are a veteran Japan hand or new to the nation, whether you are a senior executive or a newly hired medical representative.P. Reed Maurer shares his decades of experience and expertise through brilliantly penned colums that are always interesting, frequently funny, and sometimes--as in the title piece--gripping. In succinct and thoroughly enjoyable prose, Maurer imparts the esence of what you will need to know to succeed in Japan.The columns collected in this volume provide a sweeping historical perspective on Japan's pharmaceutical industry and an inside view of how companies in that industry compete. They furnish practical hints about how to manage and motivate people effectively at pharmaceutical operations in Japan and how to build a strong corporate image there. Maurer exposes myths and misunderstandings about doing business in Japan, refuting them with an objective clarity that is a joy to read.It's Worth Doing is even more, however, than a treasure trove of information and insight. True to its title, the book is a compelling reminder of why you are in the pharmaceutical business.Rob SchrullPresidentGlobal Business Leaders Association

They Do Well Who Do Good is a collection of articles written from 2000 to 2010 that document the changes in the Japan health care system and pharma industry. Changes considered impossible in the past became routine. As the decade ended, optimists and game changers leave the pessimists and status quo keepers behind. An attractive health care system evolved to care for an aging population with chronic diseases versus a young population with acute diseases. Japan wants the best health care the world has to offer, but choices must be made because resources to pay the bill are limited. In the beginning of the decade, you could compare Japanese pharma companies to a convoy of ships. Some big, some small, some fast, some slow, but all moved together. Ten years later, the convoy analogy was no longer useful. Some went abroad, others stayed home. Some divested noncore businesses; others did not. Some merged; others choose to go alone. Some changed their business models and cultures. Other rejected change and held on to their past. They Do Well Who Do Good is an insider's perspective on what it takes to succeed in Japan's pharma market.

It's Worth Doing is a must read for anyone engaged in cross-border dealings with Japan in the pharmaceutical industry. This book offers a wealth of insight that you will find invaluable whether you are a veteran Japan hand or new to the nation, whether you are a senior executive or a newly hired medical representative.P. Reed Maurer shares his decades of experience and expertise through brilliantly penned colums that are always interesting, frequently funny, and sometimes--as in the title piece--gripping. In succinct and thoroughly enjoyable prose, Maurer imparts the esence of what you will need to know to succeed in Japan.The columns collected in this volume provide a sweeping historical perspective on Japan's pharmaceutical industry and an inside view of how companies in that industry compete. They furnish practical hints about how to manage and motivate people effectively at pharmaceutical operations in Japan and how to build a strong corporate image there. Maurer exposes myths and misunderstandings about doing business in Japan, refuting them with an objective clarity that is a joy to read.It's Worth Doing is even more, however, than a treasure trove of information and insight. True to its title, the book is a compelling reminder of why you are in the pharmaceutical business.Rob SchrullPresidentGlobal Business Leaders Association